Post-operative
nausea and
vomiting is one of the complications of anaesthesia given to the patients at
the time of a surgery. The state of having unpleasant sensation subjected to
desire of vomiting is known as nausea whereas, vomiting is the forceful
expulsion contents present in gastrointestinal tracts.
Access
Detailed Report Summary:
https://www.pharmaproff.com/report/post-operative-nausea-and-vomiting-therapeutics-pipeline-analysis
The
chemoreceptor trigger zone, vagal mucosal pathway, neuronal pathway, reflex
afferent pathway, and midbrain afferent pathway are responsible for the
stimulation of vomiting. These pathways stimulate histaminergic, cholinergic,
and dopaminergic receptors to activate the sensation of vomiting. In the
postrema region, neurokinin-1 receptors are present which also play an
important role in emesis (action of vomiting).
Request
to Get the Sample Pages at:
Camurus AB
is in the process of developing CAM2058 as a serotonin 3 receptor antagonist
for the treatment of post-operative nausea and vomiting. Some of the companies
and universities having the pipeline of post-operative nausea and. Further,
universities like the University of British Columbia and Assiut University are
also involved in the pipeline for post-operative nausea and vomiting.
The report
provides a comprehensive understanding of the pipeline activities covering all
drug candidates under various stages of development, with the detailed analysis
of pipeline and clinical trials.
Pipeline analysis
of drugs by phases includes product description and development activities
including information about clinical results, designations, collaborations,
licensing, grants, technology, and others.
No comments:
Post a Comment